The Zacks Analyst Blog Highlights: Vertex Pharma, Amgen, Blueprint Medicines, Deciphera Pharma and CTI BioPharma

Published on December 3, 2021

The Zacks Analyst Blog Highlights: Vertex Pharma, Amgen, Blueprint Medicines, Deciphera Pharma and CTI BioPharma

Continue reading on website
Other news

2 Digital Transformation Stocks Investors Should Buy Right Now

December 3, 2021
Digital transformation shows no signs of slowing. And consistent innovations in AI and IoT are expected to accelerate this trend. Therefore, we think it could be wise now to scoop...

Grab These 3 Mid-Cap Growth Mutual Funds for Stellar Returns

December 3, 2021
Below we share with you three top-ranked mid-cap growth mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy).